Covid's impact looms large on the regulations horizon, especially in Western European countries, a panel considering political risk concluded at HBI 2021.
Francesco De Meo, CEO of Fresenius Helios, told HBI 2021 that Fresenius plans to expand from treating 20m patients per year in Europe to treating 100m per year globally by 2030. To achieve this he emphasised the role of asset light models with a heavy focus on digital.
Around five in ten hospitals in the UK use robotic surgery, while 65% of university hospitals in Strasbourg have less than two rooms equipped with robots. How diverse are healthcare systems across different geographies in adopting robots? At a session on digital transformation at HBI 2021, the panel asked: 'What is possible with robotic surgery today, and how is it impacting the market'?
Some revered global brands have become unstuck in their internationalisation by ceding control of a brand without any quality assurance. Panellists at HBI 2021 discussed how to manage that process more effectively.
Axa group in partnership with Microsoft has launched its digital healthcare platform in Italy and Germany this year, and has plans to launch in Spain, Belgium, and the UK in the next two weeks. An expert panel at HBI 2021 made up of Bupa, Cigna and Axa discusses how the Insurer market has changed and the future of digital platforms.
Infertility is up, maternity in many regions is down - and the global fertility market is continuing on an upwards trajectory largely untouched by Covid. It remains a hot ticket when it comes to M&A - though issues with regulation and staffing are causing some headaches.
Institutional investors are snapping up half of all new assisted living projects as they collectively up their stakes in the sector. An expert panel at HBI 2021 said that they are recognising the market as a long-term and steady investment.
There are three levels to digitalisation for healthcare providers: the foundation is clinical information systems, the middle is customer patient journey and the top is using data to understand it all. Elsan, Humanitas and Schoen Klinik talked at HBI 2021 about whether to buy or build these capabilities.
Investors and states have ploughed capex into new proton therapy machines across Europe as the machines get smaller, the range of use cases grows and more private insurers start to cover the therapy.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
